| |
DFS
| |
|---|
|
Variables
|
HR(95%CI)
|
P-value
|
|---|
|
Univariate analysis
| | |
|
Age
| | |
| ≧50 |
1.0
| |
|
< 50
|
0.82(0.28–2.38)
|
0.717
|
|
Menopause status
| | |
|
Post
|
1.0
| |
|
Pre
|
0.81(0.27–2.38)
|
0.707
|
|
Tumor size
| | |
|
< 2
|
1.0
| |
|
2 ≤ T < 5
|
1.84(0.51–6.60)
| |
|
5≥
|
19.53(4.11–92.82)
|
<0.001
|
|
Lymph node status
| | |
|
Negative
|
1.0
| |
|
Positive
|
3.78(1.18–12.07)
|
0.015
|
|
Histological grade
| | |
|
1
|
1.0
| |
|
2
|
2.25(0.64–7.89)
| |
|
3
|
2.20(0.24–20.04)
|
0.400
|
|
Multivariate analysis
| | |
|
Tumor size
| | |
|
< 2
|
1.0
| |
|
2 ≤ T < 5
|
1.49(0.39–5.61)
| |
|
5≥
|
10.18(1.79–57.75)
|
0.024
|
|
Lymph node status
| | |
|
Negative
|
1.0
| |
|
Positive
|
2.18(0.58–8.14)
|
0.207
|
- ILC invasive lobular carcinoma, DFS disease free survival, HR hazard ratio, 95 % CI 95 % confidence interval
